In suspected ACS, hs-cTnI- vs. c-cTnI-guided care was associated with improved outcomes at 5 y in certain subgroups

Jonathan Kirschner; Benton Hunter

doi:10.7326/J24-0012

In suspected ACS, hs-cTnI- vs. c-cTnI-guided care was associated with improved outcomes at 5 y in certain subgroups

Ann Intern Med. 2024 Apr;177(4):JC41. doi: 10.7326/J24-0012. Epub 2024 Apr 2.

Authors

Jonathan Kirschner¹, Benton Hunter¹

Affiliation

¹ Indiana University, Indianapolis, Indiana, USA (J.K., B.H.).

PMID: 38560903
DOI: 10.7326/J24-0012

Abstract

Lee KK, Doudesis D, Ferry AV, et al; High-STEACS Investigators. Implementation of a high sensitivity cardiac troponin I assay and risk of myocardial infarction or death at five years: observational analysis of a stepped wedge, cluster randomised controlled trial. BMJ. 2023;383:e075009. 38011922.

Publication types

Randomized Controlled Trial

MeSH terms

Acute Coronary Syndrome*
Biomarkers
Humans
Myocardial Infarction* / diagnosis
Troponin I
Troponin T

Substances

Troponin I
Biomarkers
Troponin T